Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
Pfizer Inc. has agreed to settle more than ... GSK has settled some Zantac cases before they could go to trial. News of the Pfizer settlement surfaced in a filing in state court in Delaware ...
Chicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the ...
In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez ...
A Chicago jury dismissed claims by Angela Valadez that the heartburn drug Zantac caused her colon cancer. The trial marks the first of many similar lawsuits. Drugmakers GSK and Boehringer Ingelheim ...
Recent health news covers various incidents, including a fire at Novo Nordisk’s headquarters, mergers by Gerresheimer and Biogen, avian flu cases in humans, and lawsuits against Johnson & Johnson.
London: Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
Pfizer has agreed to pay between $200m to $250m to settle more than 10,000 US lawsuits over cancer risks associated with Zantac, Financial Times reports, citing two unidentified people briefed on the ...
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Pfizer (NYSE:PFE) has reportedly agreed to pay up to $250M to settle ... which sold Zantac between 1998 and 2006, said it continues to “vigorously defend against Zantac lawsuits, which it ...
(Reuters) – Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, ...
(Reuters) – Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, ...